metabolic pathway

(redirected from Metabolic product)
Also found in: Medical.

metabolic pathway

n
(Biochemistry) any of the sequences of biochemical reactions, catalysed by enzymes, that occur in all living cells: concerned mainly with the exchange of energy and chemicals. See also Krebs cycle
References in periodicals archive ?
CEO Mark Weinreb said the notice offers protection for the specific cell line identified for the metabolic product to be used in future preclinical/clinical testing.
Which metabolic product predominates depends on the bacteria's environmental conditions -- like light intensity, temperature, and the types of organics and nutrients available.
The researchers studied the presence of a chemical compound called 3-hydroxypropyl mercapturic acid (3-HPMA), which is a metabolic product of acrolein.
Ethanol itself is not classified as a carcinogen; however, the first metabolic product (the first thing your body breaks alcohol down into) is acetaldehyde.
Reversing deficiency and maintaining optimal serum vitamin D levels beneficially impacts biochemistry and numerous body systems; this is largely because calcitriol—the metabolic product of vitamin D—is a secosteroid hormone that targets over 200 genes in a wide variety of tissues.
Vitamin D's final metabolic product is a potent, pleiotropic, repair and maintenance, seco-steroid hormone that targets more than 200 human genes in a wide variety of tissues, meaning it has as many mechanisms of action as genes it targets.
This case illustrates the appearance of hydromorphone as a minor metabolic product of morphine in the urine of a sequestered patient on chronic, high-dose morphine therapy with no access to hydromorphone.
And since uric acid is a metabolic product of purines, a dietary control of these compounds is essential.
Because angiotensin II, the ligand for A[T.sub.1]R, is a metabolic product of angiotensin-converting enzyme (ACE), we further determined whether or not UP-induced A[T.sub.1]R-mediated MAPK activation required ACE.
University of California (Oakland, CA) has patented a method using a two-hybrid system to screen for agents that modulate the ability of a cell to degrade or to accumulate a metabolic product or to selective kill a cell or to selectively express a gene or cDNA in a cell that has a defect in its ability to degrade or to accumulate a metabolic product.
The drug, 17-alpha-hydroxy-progesterone caproate (17P), is a natural metabolic product of the female hormone progesterone.